Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC | VuMedi

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

10 seconds

Playback speed

Beacon Medical Interchange

Dacomitinib: Dark Horse EGFR TKI Charges into First Line Setting for Advanced NSCLC

By Beacon Medical Interchange FEATURING Jack West

By Beacon Medical Interchange FEATURING Jack West

144 views

November 2, 2018

Dr. Jack West reviews the results of the ARCHER-1050 trial that showed superior efficacy with ...
read more ↘

Comments 0

Login to view comments. Click here to Login